HEADER CHAPERONE 17-JAN-25 9LLV TITLE DIMER SGT2 FROM S.CEREVISIAE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SMALL GLUTAMINE-RICH TETRATRICOPEPTIDE REPEAT-CONTAINING COMPND 3 PROTEIN 2; COMPND 4 CHAIN: A, B; COMPND 5 SYNONYM: SGT/UBP,VIRAL PROTEIN U-BINDING PROTEIN; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: THE 347 TYR OF CHAINS A AND B IN 9LLV IS THE COMPND 8 EXPRESSION TAG SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE S288C; SOURCE 3 ORGANISM_TAXID: 559292; SOURCE 4 GENE: SGT2, YOR007C, UNF346; SOURCE 5 EXPRESSION_SYSTEM: ROSETTA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 3132615 KEYWDS CO-CHAPERONE, GET PATHWAY, CHAPERONE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR C.HUANG,T.JI REVDAT 1 10-DEC-25 9LLV 0 JRNL AUTH T.JI,P.GE,S.ZHANG,C.WAN,H.LIU,X.QU,F.ZHU,Q.GONG,W.XU,C.WANG, JRNL AUTH 2 Y.WANG,C.HUANG JRNL TITL REMOTE ON-OFF SWITCHING OF PROTEIN ACTIVITY BY INTRINSICALLY JRNL TITL 2 DISORDERED REGION. JRNL REF NAT.STRUCT.MOL.BIOL. V. 32 2088 2025 JRNL REFN ESSN 1545-9985 JRNL PMID 40467883 JRNL DOI 10.1038/S41594-025-01585-7 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS, CYANA REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 (CNS), GUNTERT, MUMENTHALER AND WUTHRICH (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9LLV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 02-FEB-25. REMARK 100 THE DEPOSITION ID IS D_1300055806. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 100 REMARK 210 PRESSURE : 1 PA REMARK 210 SAMPLE CONTENTS : 400 UM [U-15N] SGT2_N, 90% REMARK 210 H2O/10% D2O; 400 UM [U-15N] SGT2_ REMARK 210 T, 90% H2O/10% D2O; 600 UM [U- REMARK 210 15N] SGT2_C, 90% H2O/10% D2O; REMARK 210 600 UM [U-13C; U-15N; U-2H] SGT2_ REMARK 210 C, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 3D 1H-15N NOESY; 3D CBCA(CO)NH; REMARK 210 3D HNCACB REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE NEO REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRVIEWJ REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 20 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : ALL CALCULATED STRUCTURES REMARK 210 SUBMITTED REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THE FULL-LENGTH SGT2 STRUCTURE WAS DETERMINED ENTIRELY REMARK 210 BASED ON EXPERIMENTAL NMR DATA COLLECTED FOR THE FULL-LENGTH REMARK 210 PROTEIN. WE PERFORMED EXTENSIVE NMR EXPERIMENTS ON THE FULL- REMARK 210 LENGTH SGT2, OBTAINING COMPLETE BACKBONE, SIDE-CHAIN, AND METHYL REMARK 210 GROUP ASSIGNMENTS, AS WELL AS NOE RESTRAINTS, FOR ALL THREE REMARK 210 DOMAINS (N,TPR AND C). BOTH OUR NMR AND BIOCHEMICAL DATA REMARK 210 INDICATE THAT THE THREE DOMAINS BEHAVE INDEPENDENTLY AND DO NOT REMARK 210 FORM STABLE INTER-DOMAIN CONTACTS, RESULTING IN A HIGHLY DYNAMIC, REMARK 210 "BEADS-ON-A-STRING" ARCHITECTURE. THIS IS SUPPORTED BY THE REMARK 210 ABSENCE OF LONG-RANGE INTER-DOMAIN NOES, AS WELL AS BY EXTENSIVE REMARK 210 NMR SPECTRAL OVERLAY AND SAXS DATA, ALL OF WHICH REFLECT THE REMARK 210 TRUE SOLUTION BEHAVIOR OF THE PROTEIN. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ALA A 3 -173.63 69.46 REMARK 500 1 PHE A 60 -172.23 61.01 REMARK 500 1 HIS A 64 -69.42 65.91 REMARK 500 1 ALA A 66 -48.11 84.45 REMARK 500 1 ALA A 72 -138.79 -131.34 REMARK 500 1 SER A 73 96.30 -61.19 REMARK 500 1 LYS A 80 -87.85 -122.92 REMARK 500 1 LYS A 81 109.04 161.34 REMARK 500 1 ASP A 82 88.48 58.38 REMARK 500 1 ALA A 84 -44.92 -161.89 REMARK 500 1 ASN A 86 90.48 52.28 REMARK 500 1 ILE A 89 -46.94 70.39 REMARK 500 1 ALA A 96 -80.40 -64.93 REMARK 500 1 LYS A 106 -70.30 -73.27 REMARK 500 1 THR A 228 -39.36 -132.32 REMARK 500 1 VAL A 229 71.79 40.43 REMARK 500 1 GLN A 232 -75.98 61.80 REMARK 500 1 ARG A 234 -96.57 53.45 REMARK 500 1 ASP A 235 -40.17 76.25 REMARK 500 1 ASP A 239 -75.67 -71.87 REMARK 500 1 ALA A 240 -84.57 59.67 REMARK 500 1 SER A 241 19.53 -165.48 REMARK 500 1 ASP A 251 -6.85 68.68 REMARK 500 1 LEU A 252 -75.76 63.27 REMARK 500 1 SER A 254 -53.39 71.94 REMARK 500 1 LEU A 263 87.20 -157.23 REMARK 500 1 MET A 264 75.11 59.97 REMARK 500 1 MET A 270 -13.40 79.67 REMARK 500 1 LYS A 275 86.57 -55.12 REMARK 500 1 MET A 277 -64.83 -126.86 REMARK 500 1 SER A 278 128.91 69.06 REMARK 500 1 ALA A 282 -41.39 -132.87 REMARK 500 1 MET A 283 113.17 65.91 REMARK 500 1 GLN A 284 83.72 -68.25 REMARK 500 1 MET A 290 38.04 -95.08 REMARK 500 1 GLN A 291 98.07 -62.43 REMARK 500 1 ASP A 292 135.96 68.08 REMARK 500 1 GLN A 297 88.79 -59.82 REMARK 500 1 MET A 298 16.90 56.10 REMARK 500 1 GLU A 300 138.11 71.08 REMARK 500 1 SER A 304 -56.20 -142.00 REMARK 500 1 PRO A 309 -167.54 -76.54 REMARK 500 1 PRO A 318 42.27 -80.98 REMARK 500 1 ARG A 321 -53.10 -165.80 REMARK 500 1 ASN A 322 105.53 69.08 REMARK 500 1 GLN A 334 88.73 -64.06 REMARK 500 1 SER A 335 -53.50 -155.14 REMARK 500 1 GLU A 338 -30.28 81.49 REMARK 500 1 ASP A 341 -82.87 71.49 REMARK 500 1 ASN A 342 -62.35 68.42 REMARK 500 REMARK 500 THIS ENTRY HAS 2216 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLU A 226 LYS A 227 5 -136.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 18341 RELATED DB: BMRB REMARK 900 RELATED ID: 27044 RELATED DB: BMRB REMARK 900 RELATED ID: 52887 RELATED DB: BMRB DBREF 9LLV A 1 346 UNP Q12118 SGT2_YEAST 1 346 DBREF 9LLV B 1 346 UNP Q12118 SGT2_YEAST 1 346 SEQADV 9LLV TYR A 347 UNP Q12118 EXPRESSION TAG SEQADV 9LLV TYR B 347 UNP Q12118 EXPRESSION TAG SEQRES 1 A 347 MET SER ALA SER LYS GLU GLU ILE ALA ALA LEU ILE VAL SEQRES 2 A 347 ASN TYR PHE SER SER ILE VAL GLU LYS LYS GLU ILE SER SEQRES 3 A 347 GLU ASP GLY ALA ASP SER LEU ASN VAL ALA MET ASP CYS SEQRES 4 A 347 ILE SER GLU ALA PHE GLY PHE GLU ARG GLU ALA VAL SER SEQRES 5 A 347 GLY ILE LEU GLY LYS SER GLU PHE LYS GLY GLN HIS LEU SEQRES 6 A 347 ALA ASP ILE LEU ASN SER ALA SER ARG VAL PRO GLU SER SEQRES 7 A 347 ASN LYS LYS ASP ASP ALA GLU ASN VAL GLU ILE ASN ILE SEQRES 8 A 347 PRO GLU ASP ASP ALA GLU THR LYS ALA LYS ALA GLU ASP SEQRES 9 A 347 LEU LYS MET GLN GLY ASN LYS ALA MET ALA ASN LYS ASP SEQRES 10 A 347 TYR GLU LEU ALA ILE ASN LYS TYR THR GLU ALA ILE LYS SEQRES 11 A 347 VAL LEU PRO THR ASN ALA ILE TYR TYR ALA ASN ARG ALA SEQRES 12 A 347 ALA ALA HIS SER SER LEU LYS GLU TYR ASP GLN ALA VAL SEQRES 13 A 347 LYS ASP ALA GLU SER ALA ILE SER ILE ASP PRO SER TYR SEQRES 14 A 347 PHE ARG GLY TYR SER ARG LEU GLY PHE ALA LYS TYR ALA SEQRES 15 A 347 GLN GLY LYS PRO GLU GLU ALA LEU GLU ALA TYR LYS LYS SEQRES 16 A 347 VAL LEU ASP ILE GLU GLY ASP ASN ALA THR GLU ALA MET SEQRES 17 A 347 LYS ARG ASP TYR GLU SER ALA LYS LYS LYS VAL GLU GLN SEQRES 18 A 347 SER LEU ASN LEU GLU LYS THR VAL PRO GLU GLN SER ARG SEQRES 19 A 347 ASP ALA ASP VAL ASP ALA SER GLN GLY ALA SER ALA GLY SEQRES 20 A 347 GLY LEU PRO ASP LEU GLY SER LEU LEU GLY GLY GLY LEU SEQRES 21 A 347 GLY GLY LEU MET ASN ASN PRO GLN LEU MET GLN ALA ALA SEQRES 22 A 347 GLN LYS MET MET SER ASN PRO GLY ALA MET GLN ASN ILE SEQRES 23 A 347 GLN LYS MET MET GLN ASP PRO SER ILE ARG GLN MET ALA SEQRES 24 A 347 GLU GLY PHE ALA SER GLY GLY GLY THR PRO ASN LEU SER SEQRES 25 A 347 ASP LEU MET ASN ASN PRO ALA LEU ARG ASN MET ALA GLY SEQRES 26 A 347 ASN LEU PHE GLY GLY ALA GLY ALA GLN SER THR ASP GLU SEQRES 27 A 347 THR PRO ASP ASN GLU ASN LYS GLN TYR SEQRES 1 B 347 MET SER ALA SER LYS GLU GLU ILE ALA ALA LEU ILE VAL SEQRES 2 B 347 ASN TYR PHE SER SER ILE VAL GLU LYS LYS GLU ILE SER SEQRES 3 B 347 GLU ASP GLY ALA ASP SER LEU ASN VAL ALA MET ASP CYS SEQRES 4 B 347 ILE SER GLU ALA PHE GLY PHE GLU ARG GLU ALA VAL SER SEQRES 5 B 347 GLY ILE LEU GLY LYS SER GLU PHE LYS GLY GLN HIS LEU SEQRES 6 B 347 ALA ASP ILE LEU ASN SER ALA SER ARG VAL PRO GLU SER SEQRES 7 B 347 ASN LYS LYS ASP ASP ALA GLU ASN VAL GLU ILE ASN ILE SEQRES 8 B 347 PRO GLU ASP ASP ALA GLU THR LYS ALA LYS ALA GLU ASP SEQRES 9 B 347 LEU LYS MET GLN GLY ASN LYS ALA MET ALA ASN LYS ASP SEQRES 10 B 347 TYR GLU LEU ALA ILE ASN LYS TYR THR GLU ALA ILE LYS SEQRES 11 B 347 VAL LEU PRO THR ASN ALA ILE TYR TYR ALA ASN ARG ALA SEQRES 12 B 347 ALA ALA HIS SER SER LEU LYS GLU TYR ASP GLN ALA VAL SEQRES 13 B 347 LYS ASP ALA GLU SER ALA ILE SER ILE ASP PRO SER TYR SEQRES 14 B 347 PHE ARG GLY TYR SER ARG LEU GLY PHE ALA LYS TYR ALA SEQRES 15 B 347 GLN GLY LYS PRO GLU GLU ALA LEU GLU ALA TYR LYS LYS SEQRES 16 B 347 VAL LEU ASP ILE GLU GLY ASP ASN ALA THR GLU ALA MET SEQRES 17 B 347 LYS ARG ASP TYR GLU SER ALA LYS LYS LYS VAL GLU GLN SEQRES 18 B 347 SER LEU ASN LEU GLU LYS THR VAL PRO GLU GLN SER ARG SEQRES 19 B 347 ASP ALA ASP VAL ASP ALA SER GLN GLY ALA SER ALA GLY SEQRES 20 B 347 GLY LEU PRO ASP LEU GLY SER LEU LEU GLY GLY GLY LEU SEQRES 21 B 347 GLY GLY LEU MET ASN ASN PRO GLN LEU MET GLN ALA ALA SEQRES 22 B 347 GLN LYS MET MET SER ASN PRO GLY ALA MET GLN ASN ILE SEQRES 23 B 347 GLN LYS MET MET GLN ASP PRO SER ILE ARG GLN MET ALA SEQRES 24 B 347 GLU GLY PHE ALA SER GLY GLY GLY THR PRO ASN LEU SER SEQRES 25 B 347 ASP LEU MET ASN ASN PRO ALA LEU ARG ASN MET ALA GLY SEQRES 26 B 347 ASN LEU PHE GLY GLY ALA GLY ALA GLN SER THR ASP GLU SEQRES 27 B 347 THR PRO ASP ASN GLU ASN LYS GLN TYR HELIX 1 AA1 SER A 4 LYS A 23 1 20 HELIX 2 AA2 SER A 26 GLY A 45 1 20 HELIX 3 AA3 ALA A 50 LYS A 57 1 8 HELIX 4 AA4 THR A 98 ASN A 115 1 18 HELIX 5 AA5 ASP A 117 LEU A 132 1 16 HELIX 6 AA6 ASN A 135 LEU A 149 1 15 HELIX 7 AA7 GLU A 151 ASP A 166 1 16 HELIX 8 AA8 PHE A 170 GLN A 183 1 14 HELIX 9 AA9 LYS A 185 GLU A 200 1 16 HELIX 10 AB1 THR A 205 SER A 222 1 18 HELIX 11 AB2 LEU A 311 ASN A 316 5 6 HELIX 12 AB3 SER B 4 LYS B 23 1 20 HELIX 13 AB4 ALA B 30 GLY B 45 1 16 HELIX 14 AB5 GLU B 47 GLU B 49 5 3 HELIX 15 AB6 ALA B 50 LYS B 57 1 8 HELIX 16 AB7 GLU B 97 ASN B 115 1 19 HELIX 17 AB8 ASP B 117 LYS B 130 1 14 HELIX 18 AB9 ALA B 136 LEU B 149 1 14 HELIX 19 AC1 GLU B 151 ASP B 166 1 16 HELIX 20 AC2 TYR B 169 GLN B 183 1 15 HELIX 21 AC3 LYS B 185 GLY B 201 1 17 HELIX 22 AC4 THR B 205 ASN B 224 1 20 HELIX 23 AC5 ARG B 234 ASP B 239 1 6 HELIX 24 AC6 GLN B 271 LYS B 275 5 5 HELIX 25 AC7 LEU B 311 ASN B 316 1 6 HELIX 26 AC8 SER B 335 THR B 339 5 5 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 ENDMDL MODEL 2 ENDMDL MODEL 3 ENDMDL MODEL 4 ENDMDL MODEL 5 ENDMDL MODEL 6 ENDMDL MODEL 7 ENDMDL MODEL 8 ENDMDL MODEL 9 ENDMDL MODEL 10 ENDMDL MODEL 11 ENDMDL MODEL 12 ENDMDL MODEL 13 ENDMDL MODEL 14 ENDMDL MODEL 15 ENDMDL MODEL 16 ENDMDL MODEL 17 ENDMDL MODEL 18 ENDMDL MODEL 19 ENDMDL MODEL 20 ENDMDL MASTER 171 0 0 26 0 0 0 6 5230 2 0 54 END